Days at Home After Transcatheter vs Surgical Aortic Valve Replacement in Intermediate-Risk Patients

JAMA Cardiol. 2022 Jan 1;7(1):110-112. doi: 10.1001/jamacardio.2021.4036.

Abstract

This comparative effectiveness research study uses Medicare claims data to examine the total number of days at home among intermediate-risk patients recovering from transcatheter aortic valve replacement (TAVR) vs patients recovering from surgical aortic valve replacement (SAVR).

Publication types

  • Multicenter Study
  • Randomized Controlled Trial
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged, 80 and over
  • Aortic Valve / surgery*
  • Aortic Valve Stenosis / mortality
  • Aortic Valve Stenosis / surgery*
  • Blood Vessel Prosthesis Implantation / methods
  • Female
  • Follow-Up Studies
  • Heart Valve Prosthesis*
  • Humans
  • Male
  • Outpatients / statistics & numerical data*
  • Retrospective Studies
  • Survival Rate / trends
  • Transcatheter Aortic Valve Replacement / methods*
  • Treatment Outcome